Old Web
English
Sign In
Acemap
>
Paper
>
P2.02-027 Are Inflammatory Markers Predictive of Nivolumab Efficacy in Advanced Non-Small-Cell Lung Cancer (NSCLC)?
P2.02-027 Are Inflammatory Markers Predictive of Nivolumab Efficacy in Advanced Non-Small-Cell Lung Cancer (NSCLC)?
2017
J. Rogado
M.D. Fenor de la Maza
V. Pacheco Barcia
J. M. Serra
P. Toquero
B Vera
Ana Isabel Ballesteros
R. Mondejar
O. Donnay
B. Obispo
Ramon Colomer
J.M. Sánchez Torres
Keywords:
Nivolumab
non-small cell lung cancer (NSCLC)
Pathology
Medicine
Internal medicine
Oncology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
5
Citations
NaN
KQI
[]
map